Professor | 成薇婷 | 数字化转型顾问

	Upload Avatar (500 x 500)
Name	成薇婷
Contact Information	chengweiting@whu.edu.cn
Language ability	英语, 汉语
Province	湖北省

Upload Avatar (500 x 500)

Name

成薇婷

Contact Information

chengweiting@whu.edu.cn

Language ability

英语, 汉语

Province

湖北省

University/Lab Affiliation and Title	武汉大学
Faculty	Medical School
Academic Background & Achievements	1999-2004: 华中科技大学同济医学院本科学士学位 2004-2009: 华中科技大学同济医学院硕博连读博士学位目前持有湖北省自然科学基金和武汉市卫健委的资助发表了20多篇论文，其中包括10多篇SCI论文
Work Experience	2009-2015: 华中科技大学同济医学院附属中西医结合医院肿瘤科主治医师 2015-2016: 德国慕尼黑大学肿瘤药物研究中心博士后研究 2016-2023: 华中科技大学同济医学院附属中西医结合医院肿瘤科副主任医师硕士生导师 2023-至今: 武汉大学人民医院肿瘤科副主任医师硕士生导师
Awards	2019年: 卫生部《健康报》全国青年医生全明星计划50强 2011年: 武汉市科技成果奖《肺纤方对放射性肺炎的保护作用机制》

University/Lab Affiliation and Title

武汉大学

Faculty

Medical School

Academic Background & Achievements

1999-2004: 华中科技大学同济医学院本科学士学位
2004-2009: 华中科技大学同济医学院硕博连读博士学位
目前持有湖北省自然科学基金和武汉市卫健委的资助
发表了20多篇论文，其中包括10多篇SCI论文

Work Experience

2009-2015: 华中科技大学同济医学院附属中西医结合医院肿瘤科主治医师
2015-2016: 德国慕尼黑大学肿瘤药物研究中心博士后研究
2016-2023: 华中科技大学同济医学院附属中西医结合医院肿瘤科副主任医师硕士生导师
2023-至今: 武汉大学人民医院肿瘤科副主任医师硕士生导师

Awards

2019年: 卫生部《健康报》全国青年医生全明星计划50强
2011年: 武汉市科技成果奖《肺纤方对放射性肺炎的保护作用机制》

Areas of Focus	中药活性成分对肿瘤细胞能量代谢的影响自噬在恶性肿瘤疾病进程中的调控作用
Publications	Casereport: Mycobacterium neoaurum infection during ICI therapy in a hepatocellular carcinoma patient with psoriasis, Pang L, Chen JZ, Xu D, Cheng WT, 2022 Differential early diagnosis of benign versus malignant lung cancer using systematic pathway flux analysis of peripheral blood leukocytes, Li X, Li M, Qiu H, Saad C, Zhao B, Li F, Wu X, Kuang D, Tang F, Chen Y, Shu H, Zhang J, Wang Q, Huang H, Qi S, Ye C, Bryant A, Yuan X, Kurts C, Hu G, Cheng W, Mei Q, 2022 Comprehensive Analysis of Key mRNAs and lncRNAs in Osteosarcoma Response to Preoperative Chemotherapy with Prognostic Values, Li M, Cheng WT, Li H, Zhang Z, Lu XL, Deng SS, Li J, Yang CH, 2021 Complement C3 identified as an unique risk factor for disease severity among young COVID-19 patients in Wuhan, China, Cheng WT, Hornung R, Xu K, Yang CH, Li J, 2021 Analysis of clinical features of COVID-19 in cancer patients, Cheng WT, Ke YH, Yang GY, Sun H, Chen Y, Ying RY, Zeng XH, Shen D, Tang KJ, Xu K, Yu F, 2020 Tanshinone IIA ameliorates oxaliplatin-induced neurotoxicity via mitochondrial protection and autophagy promotion, Cheng WT, Xiang W, Wang S, Kai Xu, 2019 Role of Hedgehog signaling pathway in proliferation and invasion of hepatocellular carcinoma, Cheng WT, Xu K, Tian DY, Zhang ZD, Liu LJ, Chen Y, 2009 Neocarzilin A Is a Potent Inhibitor of Cancer Cell Motility Targeting VAT-1 Controlled Pathways, Gleissner CM, Pyka CL, Heydenreuter W, Gronauer TF, Atzberger C, Cheng WT, Hacker SM, Vollmar AM, Braig S, Sieberet SA, 2019 HDAC6 inhibition suppresses chondrosarcoma by restoring the expression of primary cilia, Xiang W, Guo F, Cheng WT, Zhang J, Huang J, Wang R, Ma Z, Xu K, 2017 Evaluating the role of PTH in promotion of chondrosarcoma cell proliferation and invasion by inhibiting primary cilia expression, Xiang W, Jiang T, Guo F, Xu T, Gong C, Cheng P, Zhao L, Cheng WT, Xu K, 2014 Hedgehog pathway inhibitor-4 suppresses malignant properties of chondrosarcoma cells by disturbing tumor ciliogenesis, Xiang W, Jiang T, Guo F, Gong C, Yang K, Wu Y, Huang X, Cheng WT, Xu K, 2014

Areas of Focus

中药活性成分对肿瘤细胞能量代谢的影响
自噬在恶性肿瘤疾病进程中的调控作用

Publications

Casereport: Mycobacterium neoaurum infection during ICI therapy in a hepatocellular carcinoma patient with psoriasis, Pang L, Chen JZ, Xu D, Cheng WT, 2022
Differential early diagnosis of benign versus malignant lung cancer using systematic pathway flux analysis of peripheral blood leukocytes, Li X, Li M, Qiu H, Saad C, Zhao B, Li F, Wu X, Kuang D, Tang F, Chen Y, Shu H, Zhang J, Wang Q, Huang H, Qi S, Ye C, Bryant A, Yuan X, Kurts C, Hu G, Cheng W, Mei Q, 2022
Comprehensive Analysis of Key mRNAs and lncRNAs in Osteosarcoma Response to Preoperative Chemotherapy with Prognostic Values, Li M, Cheng WT, Li H, Zhang Z, Lu XL, Deng SS, Li J, Yang CH, 2021
Complement C3 identified as an unique risk factor for disease severity among young COVID-19 patients in Wuhan, China, Cheng WT, Hornung R, Xu K, Yang CH, Li J, 2021
Analysis of clinical features of COVID-19 in cancer patients, Cheng WT, Ke YH, Yang GY, Sun H, Chen Y, Ying RY, Zeng XH, Shen D, Tang KJ, Xu K, Yu F, 2020
Tanshinone IIA ameliorates oxaliplatin-induced neurotoxicity via mitochondrial protection and autophagy promotion, Cheng WT, Xiang W, Wang S, Kai Xu, 2019
Role of Hedgehog signaling pathway in proliferation and invasion of hepatocellular carcinoma, Cheng WT, Xu K, Tian DY, Zhang ZD, Liu LJ, Chen Y, 2009
Neocarzilin A Is a Potent Inhibitor of Cancer Cell Motility Targeting VAT-1 Controlled Pathways, Gleissner CM, Pyka CL, Heydenreuter W, Gronauer TF, Atzberger C, Cheng WT, Hacker SM, Vollmar AM, Braig S, Sieberet SA, 2019
HDAC6 inhibition suppresses chondrosarcoma by restoring the expression of primary cilia, Xiang W, Guo F, Cheng WT, Zhang J, Huang J, Wang R, Ma Z, Xu K, 2017
Evaluating the role of PTH in promotion of chondrosarcoma cell proliferation and invasion by inhibiting primary cilia expression, Xiang W, Jiang T, Guo F, Xu T, Gong C, Cheng P, Zhao L, Cheng WT, Xu K, 2014
Hedgehog pathway inhibitor-4 suppresses malignant properties of chondrosarcoma cells by disturbing tumor ciliogenesis, Xiang W, Jiang T, Guo F, Gong C, Yang K, Wu Y, Huang X, Cheng WT, Xu K, 2014

中药肿瘤细胞能量代谢活性成分自噬恶性肿瘤调控疾病进程细胞机制治疗靶点

周宇波 - 中国科学院大学

易欣 - 武汉大学

View All

Personal Information

Academic Information

Research

联系我们

还未创建账户?

Personal Information

Academic Information

Research

联系我们